Relationship between erectile dysfunction and Helicobacter pylori: A prospective controlled pilot study

Area of Science:

• Urology
• Gastroenterology
• Infectious Diseases

Background:

• Erectile dysfunction (ED) significantly impacts quality of life.
• Arteriogenic ED, caused by penile arterial insufficiency, is a common form of ED.
• Helicobacter pylori (Hp) infection is a widespread bacterial infection with potential systemic effects.

Purpose of the Study:

• To investigate the correlation between Helicobacter pylori (Hp) infection and arteriogenic erectile dysfunction (ED).
• To explore Hp seropositivity as a potential auxiliary diagnostic marker for ED.

Main Methods:

• A case-control study involving 30 patients with arteriogenic ED and 30 healthy controls.
• Measurement of Hp-specific Immunoglobulin G (IgG) antibody levels using Enzyme-linked immunosorbent assay (ELISA).
• Assessment of C-reactive protein (CRP) levels, fasting blood glucose, and serum lipid profiles.

Main Results:

• Patients with ED exhibited significantly higher levels of Hp-specific IgG antibodies compared to controls (39.7 ± 23.2 vs. 21.0 ± 19.8 arbU/ml, p=0.001).
• Mean CRP levels were also significantly elevated in the ED group (0.3 ± 0.2 vs. 0.1 ± 0.1 mg/dl, p=0.01).
• A positive correlation was observed between ED, Hp-specific IgG levels, and CRP.

Conclusions:

• Preliminary findings suggest a potential association between Helicobacter pylori infection and arteriogenic erectile dysfunction.
• Hp seropositivity may serve as an auxiliary marker in the diagnostic workup for ED.
• Further research is warranted to confirm these findings and explore the clinical benefits of Hp eradication in ED management.